The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.

Whittum-Hudson, J A; Rudy, D; Gèrard, H; Vora, G; Davis, E; Haller, P K; Prattis, S M; Hudson, A P; Saltzman, W M; Stuart, E S

Whittum-Hudson, J A; Rudy, D; Gèrard, H; Vora, G; Davis, E; Haller, P K; Prattis, S M; Hudson, A P; Saltzman, W M; Stuart, E S.

Affiliation

Whittum-Hudson JA; Department of Internal Medicine, Wayne State University School of Medicine, 119 Lande-Immunology, 550 East Canfield Avenue, Detroit, MI 48201, USA. jhudson@med.wayne.edu

Vaccine ; 19(28-29): 4061-71, 2001 Jul 16.

Article in En | MEDLINE | ID: mdl-11427283

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Glycolipids / Chlamydia Infections / Chlamydia trachomatis / Antibodies, Anti-Idiotypic / Genital Diseases, Female Limits: Animals / Female / Humans Language: En Journal: Vaccine Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Países Bajos

Search on Google

Add to My VHL

XML

PubMed Links